281 related articles for article (PubMed ID: 20035977)
1. Economic costs of overactive bladder in the United States.
Ganz ML; Smalarz AM; Krupski TL; Anger JT; Hu JC; Wittrup-Jensen KU; Pashos CL
Urology; 2010 Mar; 75(3):526-32, 532.e1-18. PubMed ID: 20035977
[TBL] [Abstract][Full Text] [Related]
2. The total economic burden of overactive bladder in the United States: a disease-specific approach.
Onukwugha E; Zuckerman IH; McNally D; Coyne KS; Vats V; Mullins CD
Am J Manag Care; 2009 Mar; 15(4 Suppl):S90-7. PubMed ID: 19355803
[TBL] [Abstract][Full Text] [Related]
3. Estimated cost of overactive bladder in Thailand.
Prasopsanti K; Santi-Ngamkun A; Pornprasit K
J Med Assoc Thai; 2007 Nov; 90(11):2316-20. PubMed ID: 18181313
[TBL] [Abstract][Full Text] [Related]
4. The economic impact of overactive bladder syndrome in six Western countries.
Irwin DE; Mungapen L; Milsom I; Kopp Z; Reeves P; Kelleher C
BJU Int; 2009 Jan; 103(2):202-9. PubMed ID: 19278532
[TBL] [Abstract][Full Text] [Related]
5. The economic costs of overactive bladder in Germany.
Klotz T; Brüggenjürgen B; Burkart M; Resch A
Eur Urol; 2007 Jun; 51(6):1654-62; discussion 1662-3. PubMed ID: 17161521
[TBL] [Abstract][Full Text] [Related]
6. The current and future burden and cost of overactive bladder in five European countries.
Reeves P; Irwin D; Kelleher C; Milsom I; Kopp Z; Calvert N; Lloyd A
Eur Urol; 2006 Nov; 50(5):1050-7. PubMed ID: 16753252
[TBL] [Abstract][Full Text] [Related]
7. Costs of urinary incontinence and overactive bladder in the United States: a comparative study.
Hu TW; Wagner TH; Bentkover JD; Leblanc K; Zhou SZ; Hunt T
Urology; 2004 Mar; 63(3):461-5. PubMed ID: 15028438
[TBL] [Abstract][Full Text] [Related]
8. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
9. Health-related consequences of overactive bladder.
Wagner TH; Hu TW; Bentkover J; LeBlanc K; Stewart W; Corey R; Zhou Z; Hunt T
Am J Manag Care; 2002 Dec; 8(19 Suppl):S598-607. PubMed ID: 12516954
[TBL] [Abstract][Full Text] [Related]
10. Costs of illness: United States, 1980.
Parsons PE; Lichtenstein R; Berki SE; Murt HA; Lepkowski JM; Stehouwer SA; Landis JR
Natl Med Care Util Expend Surv C; 1986 Apr; (3):1-90. PubMed ID: 10313412
[TBL] [Abstract][Full Text] [Related]
11. Economic burden of urgency urinary incontinence in the United States: a systematic review.
Coyne KS; Wein A; Nicholson S; Kvasz M; Chen CI; Milsom I
J Manag Care Pharm; 2014 Feb; 20(2):130-40. PubMed ID: 24456314
[TBL] [Abstract][Full Text] [Related]
12. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
13. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.
Birnbaum HG; Kessler RC; Lowe SW; Secnik K; Greenberg PE; Leong SA; Swensen AR
Curr Med Res Opin; 2005 Feb; 21(2):195-206. PubMed ID: 15801990
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy adherence and costs versus nonpharmacologic management in overactive bladder.
Pelletier EM; Vats V; Clemens JQ
Am J Manag Care; 2009 Mar; 15(4 Suppl):S108-14. PubMed ID: 19355799
[TBL] [Abstract][Full Text] [Related]
15. The annual impact of seasonal influenza in the US: measuring disease burden and costs.
Molinari NA; Ortega-Sanchez IR; Messonnier ML; Thompson WW; Wortley PM; Weintraub E; Bridges CB
Vaccine; 2007 Jun; 25(27):5086-96. PubMed ID: 17544181
[TBL] [Abstract][Full Text] [Related]
16. [Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database].
Lim SJ; Kim HJ; Nam CM; Chang HS; Jang YH; Kim S; Kang HY
J Prev Med Public Health; 2009 Jul; 42(4):251-60. PubMed ID: 19675402
[TBL] [Abstract][Full Text] [Related]
17. Economic considerations in overactive bladder.
Hu TW; Wagner TH
Am J Manag Care; 2000 Jul; 6(11 Suppl):S591-8. PubMed ID: 11183902
[TBL] [Abstract][Full Text] [Related]
18. [Economic impact of overactive bladder symptoms in Japan].
Inoue S; Kobayashi M; Sugaya K
Nihon Hinyokika Gakkai Zasshi; 2008 Nov; 99(7):713-22. PubMed ID: 19068687
[TBL] [Abstract][Full Text] [Related]
19. Estimating the cost of epilepsy in Europe: a review with economic modeling.
Pugliatti M; Beghi E; Forsgren L; Ekman M; Sobocki P
Epilepsia; 2007 Dec; 48(12):2224-33. PubMed ID: 18088267
[TBL] [Abstract][Full Text] [Related]
20. Health-related consequences of overactive bladder: an economic perspective.
Hu TW; Wagner TH
BJU Int; 2005 Sep; 96 Suppl 1():43-5. PubMed ID: 16086679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
